Adequan (Polysulfated Glycosaminoglycan) in Dogs
Generic: PSGAG
Adequan is a prescription injectable medication containing polysulfated glycosaminoglycan (PSGAG) used to manage osteoarthritis in dogs.
This medication is intended for dogs.
Overview
Adequan Canine (Polysulfated Glycosaminoglycan or PSGAG) is a prescription veterinary medication administered via injection, designed to aid in the management of osteoarthritis in dogs. It belongs to a class of drugs that work by supplementing and supporting the natural components of joint cartilage. Osteoarthritis is a degenerative joint disease characterized by the breakdown of cartilage, leading to pain, inflammation, and reduced mobility. Adequan aims to slow this progression and alleviate symptoms by promoting the synthesis of normal cartilage and inhibiting destructive enzymes within the joint.
While not a cure, Adequan is often used as part of a multimodal treatment plan for osteoarthritis, which may also include pain relievers, anti-inflammatory drugs, dietary supplements like Glucosamine-MSM, and physical therapy. Its administration requires veterinary oversight due to its injectable nature and potential for side effects. It is important for pet owners to understand that Adequan's effects are cumulative and may take several weeks to become fully apparent. Other supportive therapies may include Vetri-DMG or lifestyle modifications such as weight management and appropriate exercise.
The medication is particularly useful in dogs experiencing joint pain and stiffness, especially when associated with degenerative joint disease. It works systemically to support joint health rather than just targeting specific joints, potentially offering broader benefits. By bolstering the joint's natural repair mechanisms, Adequan can help improve comfort and function, allowing dogs to maintain a better quality of life despite their condition. It is crucial to consult with a veterinarian to determine if Adequan is an appropriate treatment option for an individual dog, considering the dog's overall health status and the specifics of their osteoarthritis.
What It Treats
- Osteoarthritis (Degenerative Joint Disease) in dogs: Helps to manage the pain, inflammation, and cartilage degradation associated with this condition.
- Joint pain and stiffness: Alleviates discomfort and improves mobility in dogs suffering from joint issues.
- Cartilage degradation: Supports the synthesis of new cartilage and inhibits enzymes that break down existing cartilage.
How It Works
Adequan (PSGAG) functions by acting as a source of glycosaminoglycans (GAGs), which are essential building blocks of healthy cartilage. Cartilage is the connective tissue that cushions the ends of bones within a joint, allowing for smooth, pain-free movement. In osteoarthritis, this cartilage wears down and degenerates. PSGAGs are similar in structure to the GAGs found naturally in cartilage, such as chondroitin sulfate and hyaluronic acid. When administered, these exogenous GAGs are incorporated into the joint tissues, helping to rebuild and reinforce the cartilage matrix. They also stimulate chondrocytes, the cells responsible for cartilage maintenance, to produce more proteoglycans and collagen, thereby promoting cartilage repair and regeneration. Beyond its role as a structural component, Adequan also exerts anti-inflammatory effects within the joint. It inhibits certain enzymes, like collagenase and phospholipase A2, which are involved in the inflammatory process and cartilage breakdown during osteoarthritis. By reducing the activity of these destructive enzymes, Adequan helps to slow the progression of the disease and decrease inflammation, which contributes significantly to the pain and stiffness experienced by affected dogs. This dual action of supporting cartilage structure and reducing inflammation makes Adequan a valuable therapeutic agent for managing canine osteoarthritis.
Dosage
The typical dosage and administration protocol for Adequan must be determined and supervised by a veterinarian. A common initial treatment protocol involves intramuscular injections given every few days for a specified period (e.g., 4 weeks), followed by a maintenance schedule. It is critical to follow the veterinarian's prescribed dosage, frequency, and duration of treatment precisely, as improper use can affect efficacy and safety. Do not adjust the dose or stop treatment without consulting your veterinarian.
Administration
Adequan is administered exclusively via intramuscular injection. It is not formulated for oral administration, and its effectiveness relies on proper injection technique and deposition into muscle tissue, allowing for systemic absorption and distribution to joints. Administration should only be performed by a qualified veterinary professional or under their direct supervision to ensure correct dosage, site, and technique. Do not attempt to administer this medication at home unless specifically trained and authorized by your veterinarian.
Storage
Unused vials of Adequan should be stored at controlled room temperature, typically between 68°F and 77°F (20°C to 25°C). Protect the medication from light. Once a vial has been punctured, it should be refrigerated and used within a specified timeframe as directed by the manufacturer or your veterinarian, usually within 14 to 28 days, to maintain sterility and potency. Always check the expiration date on the packaging and dispose of expired medication properly.
Contraindications
Adequan should not be used in dogs with known hypersensitivity to polysulfated glycosaminoglycans. Due to its potential to affect blood clotting, it should be used with caution or avoided in dogs with bleeding disorders or those currently receiving anticoagulant therapy. While not a direct contraindication, its use in conjunction with other joint supplements or medications should be discussed with a veterinarian to avoid potential interactions or overlapping effects. Adequan is not intended for use in humans. Ensure your veterinarian is aware of all other medications, supplements, and health conditions your dog is experiencing before starting Adequan.
Interactions
Adequan is generally considered to have a low potential for drug interactions, but caution is advised when used concurrently with other medications that affect blood clotting, such as warfarin or certain non-steroidal anti-inflammatory drugs (NSAIDs) used long-term. Because Adequan itself may have mild anticoagulant effects or influence platelet function, combining it with other agents that affect coagulation could theoretically increase the risk of bleeding. Always inform your veterinarian of all medications, including over-the-counter drugs, supplements (like [Coenzyme Q10](/medications/coenzyme-q10-in-dogs-and-cats) or [Bromelain](/medications/bromelain-in-dogs-and-cats)), and herbal remedies, that your dog is currently taking. Your veterinarian will assess the potential for interactions and adjust treatment plans accordingly to ensure your dog's safety. Other medications like [Denamarin](/medications/denamarin-in-dogs-and-cats) or [FortiFlora](/medications/fortiflora-in-dogs-and-cats) are unlikely to interact but should still be disclosed to your vet.
Side Effects
- Common: Mild pain, swelling, or bruising at the injection site. These are usually temporary and resolve on their own.
- Serious: Allergic reactions (though rare) can manifest as hives, facial swelling, difficulty breathing, or lethargy. Gastrointestinal upset (vomiting, diarrhea) has been reported less commonly. Any signs of adverse reaction should be reported to a veterinarian immediately.
Sources & References
Frequently Asked Questions
This information is educational only and not a substitute for professional veterinary advice. Always consult a licensed veterinarian before starting or changing any medication.


